Shares of Veradermics, Incorporated (MANE) are surging about 44 percent during Monday morning trading after the company announced positive topline results in the Phase 2/3 trial for VDPHL01, an oral formulation of minoxidil for treating male pattern hair loss.
The company's shares are currently trading at $97.67 on the New York Stock Exchange, up 44.18 percent. The stock opened at $81.07 and has climbed as high as $101.81 so far in today's session. Over the past year, it has traded in a range of $32.00 to $101.81.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.